New study aims to sharpen rectal cancer treatment by tracking Real-World data
NCT ID NCT07501845
First seen Apr 08, 2026 · Last updated Jun 11, 2026 · Updated 11 times
Summary
This study collects information from up to 999 rectal cancer patients treated with the MAASTRO HDR applicator. The goal is to learn how different radiation doses affect tumor response and side effects, helping doctors choose the best treatment for future patients. Participants receive standard care and allow their health data to be tracked for up to 10 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maastro
RECRUITINGMaastricht, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.